KR100981555B1 - The Novel Preparation Method Of 2R,3S-3-substitutedmethyl-oxiran-2-yl methanol - Google Patents

The Novel Preparation Method Of 2R,3S-3-substitutedmethyl-oxiran-2-yl methanol Download PDF

Info

Publication number
KR100981555B1
KR100981555B1 KR1020080024937A KR20080024937A KR100981555B1 KR 100981555 B1 KR100981555 B1 KR 100981555B1 KR 1020080024937 A KR1020080024937 A KR 1020080024937A KR 20080024937 A KR20080024937 A KR 20080024937A KR 100981555 B1 KR100981555 B1 KR 100981555B1
Authority
KR
South Korea
Prior art keywords
buffer
ppl
formula
solvent
organic solvent
Prior art date
Application number
KR1020080024937A
Other languages
Korean (ko)
Other versions
KR20090099763A (en
Inventor
정진현
심유란
왕방
문한서
Original Assignee
경희대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 경희대학교 산학협력단 filed Critical 경희대학교 산학협력단
Priority to KR1020080024937A priority Critical patent/KR100981555B1/en
Publication of KR20090099763A publication Critical patent/KR20090099763A/en
Application granted granted Critical
Publication of KR100981555B1 publication Critical patent/KR100981555B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/04Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with air or molecular oxygen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

본 발명은 라세미체인 시스-(3-(치환된메틸)옥시란-2-일)메틸아세테이트를 반응용매 중에 효소 PPL(porcine pancreatic lipase)로 가수분해시켜 동적분할하는 단계를 포함하는 광학이성질체인 (2R,3S)-(3-(치환된메틸)-옥시란-2-일)메탄올을 고순도 및 고수율로 제조하는 방법을 제공한다. The present invention is an optical isomer comprising the step of hydrolyzing a racemate cis- (3- (substituted methyl) oxiran-2-yl) methyl acetate with a hydrolysis enzyme PPL (porcine pancreatic lipase) in a reaction solvent. Provided is a process for preparing (2R, 3S)-(3- (substitutedmethyl) -oxirane-2-yl) methanol in high purity and high yield.

PPL(porcine pancreatic lipase), 동적분할, 광학이성질체 Porcine pancreatic lipase (PPL), dynamic splitting, optical isomer

Description

(2R,3S)-(3-(치환된메틸)-옥시란-2-일)메탄올의 신규한 제조방법{The Novel Preparation Method Of (2R,3S)-(3-(substitutedmethyl)-oxiran-2-yl) methanol}Novel Preparation Method Of (2R, 3S)-(3- (substitutedmethyl) -oxiran-2 (2R, 3S)-(3- (substitutedmethyl) -oxirane-2-yl) methanol -yl) methanol}

본 발명은 (2R,3S)-(3-(치환된메틸)-옥시란-2-일)메탄올을 입체선택적으로 제조하는 방법에 관한 것이다. The present invention relates to a process for the stereoselective preparation of (2R, 3S)-(3- (substitutedmethyl) -oxirane-2-yl) methanol.

3-(벤질옥시메틸)옥시란-2-카르브알데히드는 하기 구조식1으로 나타낼수 있으며 4개의 탄소 모두가 완전하게 기능화된 화합물로서 생물학적 활성 천연물의 중요한 구성 단위이다(Lanier. M.; Pastor, R. Tetrahedron Lett. 1995, 36, 2491-2492; (b) Righi, G.; Rumboldt, G. J. Org . Chem. 1996, 61, 3557-3560; (c) Concellon, J. M.; Bardales, E. Org . Lett . 2002, 4, 189-191; (d) Ichikawa, E.; Kato, K. Synthesis 2002, 1-28; (e) Tosaki, S.; Nemoto, T.; Ohshima, T.; Shibasaki, M. Org. Lett . 2003, 5, 495-498; (f) Concellon, J. M.; Bardales, E.; Llavona, R. J. Org . Chem . 2003, 68, 1585-1588. 참고)(하기 구조식 1에서, Bn은 벤질기를 의미한다). 3- (benzyloxymethyl) oxirane-2-carbaldehyde can be represented by the following structural formula 1, and all four carbons are fully functionalized compounds and are important structural units of biologically active natural products (Lanier. M .; Pastor, R. Tetrahedron Lett . 1995 , 36 , 2491-2492; (b) Righi, G .; Rumboldt, G. J. Org . Chem . 1996 , 61 , 3557-3560; (c) Concellon, JM; Bardales, E. Org . Lett . 2002 , 4 , 189-191; (d) Ichikawa, E .; Kato, K. Synthesis 2002 , 1-28; (e) Tosaki, S .; Nemoto, T .; Ohshima, T .; Shibasaki, M. Org. Lett . 2003 , 5 , 495-498; (f) Concellon, JM; Bardales, E .; Llavona, R. J. Org . Chem . 2003 , 68 , 1585-1588. (In Structural Formula 1 below, Bn means benzyl group).

[구조식 1][Formula 1]

Figure 112008019594662-pat00001
Figure 112008019594662-pat00001

특히 상기 구조식 1의 화합물 중 광학이성질적으로 순수한 이성질체는 위치선택적(regioselective) 및 입체선택적(stereoselective) 고리 열림 반응, 상호교환반응(metathesis) 또는 비대칭 알돌 응축반응(asymmetric aldol condensation)을 통한 전합성에서 다양한 중간체로 사용된다. 예를 들어, 상기 구조식 1의 시스-화합물의 아세토니드(acetonide) 형태는 고리형 구아니딘-당(cyclic guanidine-sugar)의 전합성에서 출발물질로 사용되며, 시스-화합물의 3탄소 위치에 메틸기가 치환된 화합물은 포막틴A(phomactin A)의 3개의 고리 내부를 구성하는 결정적인 중간체로 사용된다(Mohr, P. J.; Halcomb, R. L. Org . Lett . 2002, 4, 2413-2416 참조).In particular, the optically purely isomer of the compound of Formula 1 may be used in total synthesis through regioselective and stereoselective ring opening reaction, exchange reaction (metathesis) or asymmetric aldol condensation. Used as various intermediates. For example, the acetonide form of the cis-compound of Structural Formula 1 is used as a starting material in the total synthesis of cyclic guanidine-sugar, and the methyl group is located at the 3-carbon position of the cis-compound. Substituted compounds are used as critical intermediates that constitute the interior of the three rings of phomactin A (see Mohr, PJ; Halcomb, RL Org . Lett . 2002 , 4 , 2413-2416).

또한, 상기 구조식의 화합물은 베이리스-힐만 반응[Baylis-Hillman reaction(Krishna, P. R.; Lopinti, K. R.; Kannan, V. Tetrahedron Lett . 2004, 45, 7874-7850 참조)], 위티그 반응[Wittig reaction(Choudary, B. M.; Mahendar, K.; Kantam, M. L.; Ranganath, K. V. S.; Athar, T. Adv . Synth . Cactal . 2006, 348, 1977-1985 참조)], 무카이야마 알돌리세이션[Mukaiyama aldolisation(Ruland, Y.; Noereuil, P.; Baltas, M. Tetrahedron 2005, 61, 8895-8903 참조)]과 같은 다양한 반응 방법 개발을 위한 선구물질로 사용된다. In addition, the compound of the formula Baylis-Hillman reaction (Krishna, PR; Lopinti, KR; Kannan, V. Tetrahedron Lett . 2004 , 45 , 7874-7850), Wittig reaction (Choudary, BM; Mahendar, K .; Kantam, ML; Ranganath, KVS;.... Athar, T Adv Synth Cactal 2006, see 348, 1977-1985), Mukai Yamato al dolrise Orientation [Mukaiyama aldolisation (Ruland, Y .; Noereuil, P. (See Baltas, M. Tetrahedron 2005 , 61 , 8895-8903).

따라서, 많은 유용한 물질의 전합성에서 중간체로 이용되는 상기 구조식 화 합물의 광학이성질체를 수득하는 효율적인 방법 개발이 현재 주요 이슈화 되고 있다. 이와 더불어, 상기 구조식1의 화합물 중 특정 광학이성질체인 (2R, 3S)-3-치환된 옥시란-2-카르브알데히드를 제조하는 방법에 있어서, 출발물질로 사용가능한 (-)-(2R, 3S)-옥시란-2-일-메탄올의 효과적인 입체선택적 방법의 개발도 요구되고 있다. Therefore, the development of efficient methods for obtaining the optical isomers of the above structural compounds, which are used as intermediates in the total synthesis of many useful materials, is currently a major issue. In addition, in the method for preparing the formula 1 compounds with certain optical isomer of (2 R, 3 S) -3- substituted oxirane-2-carbaldehyde of the, possible to use as starting material (-) - ( 2 R, 3 S) - oxiran-2-yl-is also required development of efficient stereoselective method of methanol.

PPL(porcine pancreatic lipase)은 가수분해 및 에스테르 교환반응 효소이며, 리파아제 류 중에서도 순도가 높고 생산단가가 낮으며, 다른 리파아제들 보다 더 친유성인 것으로 알려져 있다. 또한 크루드한 PPL은 수-유기용매에서 그들의 표면을 더 증가시키고, 효소 표면 주변의 내부 안에 필수적으로 존재하는 물은 리파아제 활성을 유지시키고 유기용매 중 효소의 표면에 기질이 더 잘 결합되게 한다고 보고되어진다(Hazarika, S.; Goswami, P.; Dutta, N. N.; Hazarika, A. K. Chem . Eng . J. 2002, 85, 61-68. 참조). 그러나 PPL이 분자량이 작은 분자인 옥시란(oxirane) 화합물의 동적분할(kinetic resolution)에 사용된 예는 매우 적다. 예를 들어, PPL에 의한 아세틸 교환 반응을 통한 시스-3-((벤질옥시메틸)옥시란-2-일)메탄올의 동적 분할은 시스-(+)-(2S,3R)-옥시란-2-일-메탄올이 더 잘 일어난다고 보고되어 있을 뿐이다(Ferenc Faigl Angelika Thurner Melinda Battancs Ferenc Farkas Laszlo Poppe Viktoria Bodai Ildiko Kmecz Bela Simandi Tetrahedron : Asymmetry, 2005, 16, 3841-3847 참고). 즉, 현재까지 PPL 효소를 이용한 (-)-(2R, 3S)-옥시란-2-일 -메탄올의 효과적인 동적 분할은 보고된바가 없다. Porcine pancreatic lipase (PPL) is a hydrolysis and transesterification enzyme, and has high purity and low production cost among lipases, and is known to be more lipophilic than other lipases. Crude PPL also increases their surface in water-organic solvents, and water, which is essentially present in the interior around the enzyme surface, maintains lipase activity and allows the substrate to bind better to the surface of the enzyme in organic solvents. (See Hazarika, S .; Goswami, P .; Dutta, NN; Hazarika, AK Chem . Eng . J. 2002 , 85 , 61-68.). However, very few examples of PPL have been used for kinetic resolution of oxirane compounds, which are molecules of low molecular weight. For example, the dynamic cleavage of cis-3-((benzyloxymethyl) oxan-2-yl) methanol via acetyl exchange reaction with PPL is cis-(+)-(2S, 3R) -oxirane-2 It is only reported that day-methanol occurs better (see Ferenc Faigl Angelika Thurner Melinda Battancs Ferenc Farkas Laszlo Poppe Viktoria Bodai Ildiko Kmecz Bela Simandi Tetrahedron : Asymmetry , 2005 , 16 , 3841-3847). That is, using a PPL enzyme to the present (-) - (2 R, 3 S) - has not been reported effective dynamic partitioning of methanol-oxiran-2-yl.

본 발명의 목적은 (2R,3S)-(3-(치환된메틸)-옥시란-2-일)메탄올을 입체선택적으로 제조하는 방법을 제공하는데 있다. It is an object of the present invention to provide a process for the stereoselective preparation of (2R, 3S)-(3- (substitutedmethyl) -oxirane-2-yl) methanol.

본 발명은 라세미체인 하기 화학식1 화합물을 반응용매 중에서 효소 PPL(porcine pancreatic lipase)로 가수분해시켜 동적분할하는 단계를 포함하는 광학이성질체인 화학식2 화합물의 제조방법을 제공한다.The present invention provides a method for preparing the compound of formula (2), which is an optical isomer comprising the step of hydrolyzing the compound of formula (1) which is a racemate with the enzyme PPL (porcine pancreatic lipase) in the reaction solvent.

[화학식1] [Formula 1]

Figure 112008019594662-pat00002
Figure 112008019594662-pat00002

[화학식2](2)

Figure 112008019594662-pat00003
Figure 112008019594662-pat00003

상기식에서,In this formula,

Ac는 아세틸기를 의미하며, Ac means an acetyl group,

X는 C1~C6의 알칸, C2~C3의 알켄, 벤젠 또는 나프탈렌이며, 여기서 알칸 및 알켄은 비치환되거나, 플로로, 클로로, 브롬, 요오드, 니트로, 벤젠, 나프탈렌으로 1이상 치환된 것이며, 바람직하게는 플로로, 클로로, 브롬, 요오드, 니트로, 벤젠, 나프탈렌으로 1이상 치환된 C1~C6 알칸이며, 더욱 바람직하게는 벤질(benzyl, Bn)이다. X is C1 to C6 alkanes, C2 to C3 alkenes, benzene or naphthalene, wherein alkanes and alkenes are unsubstituted or substituted one or more with fluoro, chloro, bromine, iodine, nitro, benzene, naphthalene, preferably Preferably they are C1-C6 alkanes substituted with one or more of fluoro, chloro, bromine, iodine, nitro, benzene, naphthalene, more preferably benzyl (Bn).

본 발명의 제조방법에서, 반응 용매는 다양한 극성도를 가지는 유기용매일 수 있으며, 크실렌(xylene)이 바람직하다. 보다 바람직한 반응 용매는 완충액 및 유기용매의 혼합용매 일 수 있다. 본 발명에서 사용되는 바람직한 완충액은 pH=7.2의 포스페이트 완충액이고, 리파아제 촉매에 의해 가수분해되어 반응 환경이 점차적으로 산화될 경우 [2,2,1]-이환 올소에스테르 중간체([2,2,1]-bicyclic orthoester intermediate)의 재배열(rearrangement)을 통해 2-메틸-D-에리트리톨로 전환되는 것을 방지한다. 따라서, 완충액과 유기용매의 혼합용매의 사용은 단순히 유기용매만을 사용한 경우보다 산성 생성물을 즉시 중성화하여 생성물인 옥시란 환이 추가로 분열되는 것을 억제하는 효과가 있다. In the preparation method of the present invention, the reaction solvent may be an organic solvent having various polarities, and xylene is preferred. More preferred reaction solvent may be a mixed solvent of a buffer and an organic solvent. Preferred buffers used in the present invention are phosphate buffers with pH = 7.2, and are hydrolyzed by lipase catalysts to [2,2,1] -bicyclic oxoester intermediates when the reaction environment is gradually oxidized ([2,2,1]. ] to prevent conversion to 2-methyl-D-erythritol via rearrangement of bicyclic orthoester intermediates. Therefore, the use of the mixed solvent of the buffer and the organic solvent has an effect of inhibiting further cleavage of the oxirane ring, which is a product, by neutralizing the acidic product immediately, rather than simply using the organic solvent alone.

완충액 및 유기용매의 혼합비는 본 발명의 목적을 만족하는 한 다양하게 변화할 수 있다. 예를 들어 완충액 및 유기용매는 1:10 내지 10:1의 부피비로 혼합될 수 있으며, 바람직한 부피비는 1:1 부피비(v/v)이다. The mixing ratio of the buffer and the organic solvent can be varied in various ways as long as the object of the present invention is satisfied. For example, the buffer and the organic solvent may be mixed in a volume ratio of 1:10 to 10: 1, and a preferred volume ratio is 1: 1 volume ratio (v / v).

본 발명에서 사용되는 완충액 및 유기용매의 혼합용매에서, 유기용매의 극성도와 관계된 log P값은 3.00 내지 3.50인 것이 바람직하다. 여기서 log P는 1-옥탄올 및 물의 이중상 시스템(two- phase system)을 기준으로 한 용매의 분배계수의 로그값으로 정의되며, 극성도를 나타낸다. 이러한 유기용매의 log P값은 PPL 효소 에 의한 가수분해의 결과비와 일치하는 값으로 중요한 매개변수이다. 즉, log p값이 클수록 극성용매이다.In the mixed solvent of the buffer and the organic solvent used in the present invention, the log P value related to the polarity of the organic solvent is preferably 3.00 to 3.50. Where log P is defined as the logarithm of the partition coefficient of the solvent based on a two-phase system of 1-octanol and water, and represents polarity. The log P value of these organic solvents is an important parameter that is consistent with the ratio of hydrolysis by PPL enzyme. In other words, the larger the log p value, the more polar the solvent.

완충액 및 유기용매의 혼합용매에서, 유기용매는 크실렌, 시클로헥산, 헥산과 같은 비극성용매가 보다 바람직하다. In the mixed solvent of the buffer and the organic solvent, the organic solvent is more preferably a nonpolar solvent such as xylene, cyclohexane, hexane.

본 발명의 완충액 및 유기용매의 혼합용매에서, 완충액은 일반 효소반응에 사용되는 완충액이라면 사용가능하다. 예를 들어, 포스페이트, 시트르산(Citric acid), 소듐 테트라보레이트(Sodium tetraborate)등을 이용한 완충액이 있으며, 바람직하게는 포스페이트를 이용한 완충액이다.In the mixed solvent of the buffer and the organic solvent of the present invention, the buffer may be used as long as it is a buffer used for a general enzyme reaction. For example, there is a buffer solution using phosphate, citric acid, sodium tetraborate, and the like, and preferably a buffer solution using phosphate.

본 발명에서 사용가능한 완충액의 pH는 본 발명에서 사용되는 PPL 효소의 활성에 영향을 미치지 않는 범위인 pH=4.0~10.5가 바람직하고, pH가 6.5 내지 7.9이 보다 바람직하며, pH가 7.2가 더욱 바람직하다. The pH of the buffer which can be used in the present invention is preferably in the range of not affecting the activity of the PPL enzyme used in the present invention, pH = 4.0 to 10.5, more preferably 6.5 to 7.9, more preferably pH 7.2. Do.

본 발명의 반응은 0℃~ 60℃에서 수행될 수 있으며, 10℃ 내지 35℃일 때 보다 바람직하다. 반응온도가 너무 낮아지면 반응속도가 늦어지고, 너무 높으면 효소의 변성이 일어난다. 바람직한 반응온도는 약 25℃이다. The reaction of the present invention may be carried out at 0 ° C ~ 60 ° C, more preferably 10 ° C to 35 ° C. If the reaction temperature is too low, the reaction rate is slowed. If the reaction temperature is too high, denaturation of the enzyme occurs. Preferred reaction temperatures are about 25 ° C.

또한 본 발명은 본 발명의 화학식2 화합물을 제조하는 단계 및 화학식2 화합물을 산화 반응시켜 화학식3의 화합물을 제조하는 단계를 포함하는 화학식3 화합물 의 제조방법을 제공한다. In another aspect, the present invention provides a method for preparing a compound of formula (3) comprising the step of preparing a compound of formula (2) of the present invention and the oxidation of the compound of formula (2) to produce a compound of formula (3).

[화학식3][Formula 3]

Figure 112008019594662-pat00004
Figure 112008019594662-pat00004

상기 식에서, Where

X는 C1~C6의 알칸, C2~C3의 알켄, 벤젠 또는 나프탈렌이며, 여기서 알칸 및 알켄은 비치환되거나, 플로로, 클로로, 브롬, 요오드, 니트로, 벤젠, 나프탈렌으로 1이상 치환된 것이며, 바람직게는 플로로, 클로로, 브롬, 요오드, 니트로, 벤젠, 나프탈렌으로 1이상 치환된 C1~C6 알칸이며, 더욱 바람직하게는 벤질(benzyl)이다.X is C1 to C6 alkanes, C2 to C3 alkenes, benzene or naphthalene, wherein alkanes and alkenes are unsubstituted or substituted one or more with fluoro, chloro, bromine, iodine, nitro, benzene, naphthalene, preferably Crab is C1 to C6 alkanes substituted with at least one of fluoro, chloro, bromine, iodine, nitro, benzene and naphthalene, more preferably benzyl.

화학식2 화합물을 화학식3 화합물로 산화시키는 방법은 1차 알코올을 알데히드로 산화시키는 공지된 방법을 이용할 수 있다. 예를 들어, Swern oxidation, PCC oxidation, 및 데스-마틴 퍼아이오딘난(Dess-Martin periodinane)을 이용하는 방법이 있으며, 바람직하게는 데스-마틴 퍼아이오딘난(Dess-Martin periodinane)을 이용하는 방법이 있다.여기서, 데스-마틴 퍼아이오딘난(Dess-Martin periodinane)은 J. Org . Chem . 1999 , 64 , 4537-4538 에 기재된 방법으로 제조한다. The method for oxidizing the compound of formula 2 to the compound of formula 3 may use a known method for oxidizing the primary alcohol with aldehyde. For example, there is a method using Swern oxidation, PCC oxidation, and Dess-Martin periodinane, and preferably, a method using Dess-Martin periodinane is used. Here, Dess-Martin periodinane is described in J. Org . Chem . It is manufactured by the method described in 1999 , 64 , 4537-4538.

본 발명은 라세미체인 시스-(3-(치환된메틸)옥시란-2-일)메틸아세테이트를 PPL효소를 이용한 동적 분할로 광학이성질체인 (2R,3S)-(3-(치환된메틸)-옥시란 -2-일)메탄올을 고수율, 고순도로 수득할 수 있다. The present invention is a dynamic isomerization of the racemate cis- (3- (substitutedmethyl) oxiran-2-yl) methylacetate using PPL enzyme, which is an optical isomer (2R, 3S)-(3- (substitutedmethyl) -Oxirane-2-yl) methanol can be obtained in high yield, high purity.

하기 실시예에 의해 본 발명을 더 상세히 설명한다. 하기 비제한적인 실시예는 본 발명의 제조방법을 예시할 뿐이며, 본 발명의 영역을 제한하지 않는다. 본 발명에 따른 제조방법은 일반적인 산업적 제조에 용이하게 적용될 수 있음을 특징으로 한다. The invention is further illustrated by the following examples. The following non-limiting examples merely illustrate the preparation of the invention and do not limit the scope of the invention. The production method according to the invention is characterized in that it can be easily applied to general industrial production.

이하에서 사용된 시료 및 PPL은 알드리치 및 시그마(Aldrich and Sigma)사로부터 구입하였다. THF(Tetrahydrofuran) 및 에틸에테르는 나트륨금속 및 벤조퀴논을 이용하고, 아르곤(Ar) 기체하에서 증류하여 사용하였으며, 디클로로메탄, 아세토니트릴 및 톨루엔은 수소화칼슘(calcium hydride)을 이용하여 증류하였다. 다른 용매들을 Aldrich, J. T. Baker, 및 Fisher 사로부터 최상급으로 구입하여 사용하였다. 효소반응은 25℃에서 160rpm으로 JEIO TECH(Korea) incubatory orbital shaker SI-300R에서 수행하였다. 전환률(conversion rate) 및 광학순도(enantiomeric excess)는 Hewlett-Packard 1200, LC(liquid chromatograph, CHIRALCEL OD)을 이용하여 키랄 HPLC(고성능액체크로마토그래피) 분석으로 측정하였다. 광학회전(Optical rotations)은 JASCO DIP-1000 디지털 편광계(digital polarimeter)으로 측정하였으며, NMR 스펙트럼은 용매로 CDCl3를 사용하고, Bruker Avance 400 분광기를 이용하여 측정하였다. 화학적 이동값(Chemical shifts)은 TMS(tetramethylsilane)의 값에 대한 상대적인 ppm 값으로 계산하였다. 커플링상수(Coupling constants)는 헤르츠(hertz)로 기재하였고, 양성 전기분무이온화[Positive electrospray ionization(ESI+)]는 Hewlett-Packard 분광기을 이용하여 측정하였다. IR 스펙트럼은 JASCO 420 FT-IR 분광기를 사용하여 측정하였다. TLC(Thin layer chromatography)는 미리 코팅된 실리카겔 플레이트(Merck 60 F254)를 사용하여 수행하였으며, 프레쉬 컬럼 크로마토그래피(Fresh column chromatography)는 실리카 겔 60(Merck, 0.040-0.063mm, 230-400 mesh)을 사용했으며, 전개 용매로 헥산 및 에틸아세테이트를 이용하였다. Samples and PPL used below were purchased from Aldrich and Sigma. THF (Tetrahydrofuran) and ethyl ether were used by distillation under argon (Ar) gas using sodium metal and benzoquinone, and dichloromethane, acetonitrile and toluene were distilled using calcium hydride. Other solvents were best purchased from Aldrich, JT Baker, and Fisher. Enzyme reaction was carried out in JEIO TECH (Korea) incubatory orbital shaker SI-300R at 160 rpm at 25 ℃. Conversion rate and enantiomeric excess were determined by Chiral HPLC (High Performance Liquid Chromatography) analysis using Hewlett-Packard 1200, liquid chromatograph (CHIRALCEL OD). Optical rotations were measured with a JASCO DIP-1000 digital polarimeter, and NMR spectra were measured using CDCl 3 as a solvent and Bruker Avance 400 spectrometer. Chemical shifts were calculated as ppm values relative to the value of tetramethylsilane (TMS). Coupling constants were reported in hertz and positive electrospray ionization (ESI + ) was measured using a Hewlett-Packard spectrometer. IR spectra were measured using a JASCO 420 FT-IR spectrometer. Thin layer chromatography (TLC) was performed using a precoated silica gel plate (Merck 60 F 254 ), and fresh column chromatography was performed on silica gel 60 (Merck, 0.040-0.063 mm, 230-400 mesh). Was used, and hexane and ethyl acetate were used as the developing solvent.

<< 제조예Production Example > 라세미체인 > Race Semi Chain 시스Sheath -3-(-3- ( 벤질옥시메틸Benzyloxymethyl )) 옥시란Oxirane -2-일)-2 days) 메틸아세테이트Methyl acetate (( 화학식1의Formula 1 화합물)의 제조 Compound)

시스-4-벤질옥시-부트-2-엔-1-올(2,425mg, 13.61mmol)의 CH2Cl2(40ml)의 용액에 0oC에서 한 번에 NaHCO3(2,172mg, 25.85mmol)을 넣고 5분간 교반한 후에, mCPBA (2,818mg, 16.33mmol)을 넣고 실온으로 온도를 상승시키면서 3시간동안 반응시켰다. 그 용액을 포화된 탄산수소나트륨수용액(25ml)으로 반응을 중단시키고, 반응용액을 CH2Cl2으로 희석시켰다. 유기층을 분리하고 수용액층을 CH2Cl2으로 3번 추출하였다. 수집한 유기층을 브라인(brine) 및 무수의 MgSO4으로 건조시키고, 용매를 진공증발시키고 잔류물을 프레쉬(fresh) 컬럼 크로마토그래피(n-hexane:EtOAc = 3:1v/v)로 분리하여 옥시란 화합물을 무색의 오일로 78%수율로 수득하였다. 옥시란 화합물(2,062mg, 10.61mmol)의 CH2Cl2(40ml)용액에, 피리딘(1.28ml, 15.94mmol), DMAP(259.64mg, 2.12mmol) 및 (CH3CO)2O (1.30ml, 12.74mmol)을 0℃에서 첨가하고 실온에서 6시간동안 교반하였다. 혼합물을 디클로로메탄(40ml)으로 희석시키고 물로 세척하였다. 유기층을 수집하고, 용매를 진공 증발시킨 후에, 잔류물을 프레쉬 컬럼 크로마토그래피(n-hexane:EtOAc=4:1v/v)하여 표제의 화합물인 아세틸화된 라세믹 에폭시드 화합물을 99% 수율(1,318mg)로 수득하였다[1H-NMR (400MHz, CDCl3) δ: 7.31 (m, 5H) 4.56 (d, J=7.2 Hz, 2H) 4.39 (m, 1H) 3.95 (q, J=12.32, J=6 Hz, 1H) 3.75 (m, 1H) 3.52 (m, 1H) 3.13 (m, 2H) 2.06 (m, 3H)]. To a solution of cis-4-benzyloxy-but-2-en-1-ol (2,425 mg, 13.61 mmol) CH 2 Cl 2 (40 ml) NaHCO 3 (2,172 mg, 25.85 mmol) at once at 0 o C After adding and stirring for 5 minutes, m CPBA (2,818mg, 16.33mmol) was added thereto and allowed to react for 3 hours while raising the temperature to room temperature. The reaction was stopped with saturated aqueous sodium hydrogen carbonate solution (25 ml) and the reaction solution was diluted with CH 2 Cl 2 . The organic layer was separated and the aqueous layer was extracted three times with CH 2 Cl 2 . The collected organic layers were dried over brine and anhydrous MgSO 4 , the solvent was evaporated in vacuo and the residue was separated by fresh column chromatography ( n -hexane: EtOAc = 3: 1v / v) to oxirane. The compound was obtained as a colorless oil in 78% yield. To a CH 2 Cl 2 (40 ml) solution of oxirane compound (2,062 mg, 10.61 mmol), pyridine (1.28 ml, 15.94 mmol), DMAP (259.64 mg, 2.12 mmol) and (CH 3 CO) 2 O (1.30 ml, 12.74 mmol) was added at 0 ° C. and stirred at rt for 6 h. The mixture was diluted with dichloromethane (40 ml) and washed with water. After collecting the organic layer and evaporating the solvent in vacuo, the residue was subjected to fresh column chromatography ( n- hexane: EtOAc = 4: 1v / v) to yield 99% yield of the title compound, acetylated racemic epoxide compound ( 1,318 mg) [ 1 H-NMR (400 MHz, CDCl 3 ) δ: 7.31 (m, 5H) 4.56 (d, J = 7.2 Hz, 2H) 4.39 (m, 1H) 3.95 (q, J = 12.32, J = 6 Hz, 1H) 3.75 (m, 1H) 3.52 (m, 1H) 3.13 (m, 2H) 2.06 (m, 3H)].

<실시예 1>순수유기용매 중에서의 (2R, 3S)-3-(벤질옥시메틸)옥시란-2-일)메탄올의 제조Example 1 Preparation of (2R, 3S) -3- (benzyloxymethyl) oxan-2-yl) methanol in a pure organic solvent

제조예에서 제조한 화합물1인 라세미체인 시스-3-(벤질옥시메틸)옥시란-2-일) 메틸아세테이트(100mg)을 하기 표1에 기재된 용매에 넣고, 효소 PPL(100mg)을 넣고, 25에서, 3시간 또는 48시간 동안 반응시켰다(반응식 1참조). To put the cis-3- (benzyloxymethyl) oxirane-2-yl) methyl acetate (100 mg) which is the racemate of the compound 1 prepared in the preparation example in the solvent shown in Table 1 below, add the enzyme PPL (100 mg), At 25, it was reacted for 3 or 48 hours (see Scheme 1).

상기 반응에서 유기용매의 성질 및 유기용매중의 기질의 용해도와 관련된 효소의 성향이 PPL에 의한 가수분해의 전환율(conversion rate) 및 E 값에 어떤 영 향을 미치는지를 알아내기 위해 반응용매에 따른 효소의 반응성을 살펴보았다. 그 반응 결과를 요약하면 표1과 같다.Enzyme according to the reaction solvent to determine how the nature of the organic solvent and the propensity of the enzyme related to the solubility of the substrate in the organic solvent affect the conversion rate and E value of hydrolysis by PPL The reactivity of The results of the reaction are summarized in Table 1.

[반응식 1]Scheme 1

Figure 112008019594662-pat00005
Figure 112008019594662-pat00005

(상기 반응식에서 Bn은 벤질기를 의미한다)(Bn in the above scheme means benzyl group)

[표1] 순수 유기용매에서의 PPL-효소의 가수분해 결과Table 1 Hydrolysis Results of PPL-Enzyme in Pure Organic Solvents

Figure 112008019594662-pat00006
Figure 112008019594662-pat00006

a Reference : Biotechnology and Bioengineering 1987, 30, (1), 81-87 a Reference: Biotechnology and Bioengineering 1987, 30, (1), 81-87

b키랄 컬럼을 사용한 HPLC 분석결과에 근거하여 전환률을 측정하였다. b Conversion rate was determined based on HPLC analysis using a chiral column.

c 키랄 컬럼을 사용한 HPLC 분석결과에 근거하여 광학순도(enantiomeric excess)를 측정하였다. The optical purity was determined based on the results of HPLC analysis using a c chiral column.

d E=ln[(1-ees)/{1+(ees/eep)}]/ln[(1+ees)/{1+(ees/eep)}] d E = ln [(1-ee s ) / {1+ (ee s / ee p )}] / ln [(1 + ee s ) / {1+ (ee s / ee p )}]

순수한 11가지의 유기용매에서의 반응식1에 따른 PPL-효소에 의한 가수분해의 전환률과 log P의 상관관계에 대한 대략적인 지표를 표1에 나타내었다. 라세믹 화합물 1의 PPL 효소에 의한 가수분해는 용매의 종류에 따라 매우 다양하게 관찰되었다. 유기용매의 종류는 라세믹 화합물 1의 E 값에 매우 중요한 영향을 미치며, log P는 전환률 및 입체선택 (enantioselectivity)에 큰 영향을 나타냄을 알 수 있었다. 표1에서 번호 1 내지 11의 결과를 보면, 헥산(log P = 3.50), 시클로헥산(log P = 3.20), 및 크실렌(log P = 3.10)과 같은 지용성 용매에서 생성물의 광학순도가 매우 높았다. 특히, 크실렌에서 라세믹 화합물 1을 PPL로 반응시켰을 때 초기 3시간에서의 E 값은 1.78로 높지 않았으나, 48시간반응 후, 95.9ee%, 67.5의 E값 및 59.45%의 전환률을 나타내어, 순수 유기용매를 사용한 PPL 반응에서 크실렌이 가장 우수한 효과를 나타내었다. Table 1 shows the approximate index of the conversion of PPL-enzyme hydrolysis and log P in 11 pure organic solvents. Hydrolysis of racemic compound 1 by PPL enzyme was observed in various ways depending on the type of solvent. The type of organic solvent was found to have a very important effect on the E value of racemic compound 1, and log P was found to have a significant effect on the conversion and enantioselectivity. The results of numbers 1 to 11 in Table 1 showed that the optical purity of the product was very high in fat-soluble solvents such as hexane (log P = 3.50), cyclohexane (log P = 3.20), and xylene (log P = 3.10). In particular, when reacted with a racemic compound 1 in xylene at PPL E value in the initial 3 hours, although with high 1.78, 48 hours of reaction, exhibits a 95.9ee%, of 67.5 and E value conversion rate of 59.45% pure organic Xylene showed the best effect in PPL reaction with solvent.

또한, 극성용매인 아세톤의 E 값은 E=5.73(3 시간)에서 E=12.67(48시간)으로 꾸준히 증가하였으며, 낮은 log P값을 가지는 에테르 유형인 테트라히드로푸란은 48시간 후에 E 값이 13.77이 였다. 또한, 테트라히드로푸란과 비슷한 log P값을 가지는 디클로로메탄은 테트라히드로푸란보다 더 높은 E값(3 시간에서 4.83, 48 시간에서 13.77) 및 전환률(3시간에서 28.93%, 48시간에서 84.34%)을 나타내었다. In addition, E value of acetone, a polar solvent, increased steadily from E = 5.73 (3 hours) to E = 12.67 (48 hours) .The tetrahydrofuran, an ether type with a low log P value, had an E value of 13.77 after 48 hours. This was. In addition, dichloromethane with a log P value similar to tetrahydrofuran showed higher E values (4.83 at 3 hours, 13.77 at 48 hours) and conversion (28.93% at 3 hours, 84.34% at 48 hours) than tetrahydrofuran. Indicated.

<실시예2> 완충액-유기용매 혼합물에서의 반응 Example 2 Reaction in Buffer-Organic Solvent Mixture

제조예에서 제조한 화합물1인 라세미체인 시스-3-(벤질옥시메틸)옥시란-2-일) 메틸아세테이트 100mg을 하기 표2에 기재된 용매 및 완충액을 1:1 부피비로 혼합한 용매 200ml에 첨가하고, PPL 100mg을 넣고, 25℃에서, 3시간 또는 48시간 동안 반응시켰다(반응식 2참조).(단, 여기서 완충액은 pH=7.2의 포스페이트 완충액을 사용하였다). 100 mg of cis-3- (benzyloxymethyl) oxiran-2-yl) methylacetate, which is the racemate of Compound 1 prepared in Preparation Example, was added to 200 ml of a solvent in which the solvent and the buffer shown in Table 2 were mixed in a 1: 1 volume ratio. 100 mg of PPL was added and reacted at 25 ° C. for 3 hours or 48 hours (see Scheme 2), except that the buffer used a phosphate buffer of pH = 7.2.

유기용매-완충액(1:1, v/v) 혼합물은 가수분해된 생성물(카르복실산)을 중성화시켜 옥시란 고리의 추가의 분열을 억제하며, 열역학적 수 활성도(Thermodynamic water activity, aw)는 염을 함유한 완충 용액으로 최대로 조정한다. 따라서, 본 발명자는 수-유기용매 시스템에서의 유기용매의 성질 및 유기용매중의 기질의 용해도와 관련된 효소의 성향이 PPL에 의한 가수분해의 전환율(conversion rate) 및 E 값에 어떤 영향을 미치는지를 알아내기 위해 반응용매에 따른 효소의 반응성을 살펴보았다. The organic solvent-buffer (1: 1, v / v) mixture neutralizes the hydrolyzed product (carboxylic acid) to inhibit further cleavage of the oxirane ring, and the thermodynamic water activity (a w ) Adjust to the maximum with the buffer solution containing the salt. Therefore, the present inventors have discussed how the nature of the organic solvent in the water-organic solvent system and the propensity of the enzyme related to the solubility of the substrate in the organic solvent affect the conversion rate and E value of hydrolysis by PPL. To find out, we examined the reactivity of the enzyme according to the reaction solvent.

[반응식 2]Scheme 2

Figure 112008019594662-pat00007
Figure 112008019594662-pat00007

[표2] 완충액 및 유기용매(1:1v/v) 혼합용매에서의 PPL-효소의 가수분해 결과Table 2 Hydrolysis Results of PPL-Enzyme in Buffer and Organic Solvents (1: 1v / v)

Figure 112008019594662-pat00008
Figure 112008019594662-pat00008

a Reference Biotechnology and Bioengineering 1987, 30, (1), 81-87 a Reference Biotechnology and Bioengineering 1987, 30, (1), 81-87

b키랄 컬럼을 사용한 HPLC 분석결과에 근거하여 전환률을 측정하였다. b Conversion rate was determined based on HPLC analysis using a chiral column.

c 키랄 컬럼을 사용한 HPLC 분석결과에 근거하여 광학순도(enantiomeric excess)를 측정하였다. The optical purity was determined based on the results of HPLC analysis using a c chiral column.

d E=ln[(1-ees)/{1+(ees/eep)}]/ln[(1+ees)/{1+(ees/eep)}] d E = ln [(1-ee s ) / {1+ (ee s / ee p )}] / ln [(1 + ee s ) / {1+ (ee s / ee p )}]

10가지의 유기용매 및 완충액을 1:1 부피비로 혼합한 용매중의 반응식2에 따른 PPL-효소에 의한 가수분해의 전환률과 log P의 상관관계에 대한 대략적인 지표를 표2에 나타내었다. 표2에 따르면, 용매의 log P값 및 완충액-유기용매에서의 PPL 효소의 가수분해의 입체선택성이 정비례하는 것은 아니지만, 크실렌, 시클로헥산 및 헥산 (번호 8 내지 10, log P는 3.10 내지 3.50의 값을 가짐)은 PPL에 의한 라세미 화합물 1 의 가수분해에 매우 효과적임을 알 수 있다. 특히 시클로헥산(번호 9)은 48시간 반응 후에 이들 3개의 용매 중에서 가장 높은 99.5ee% 및 E (>200)값을 나타내었다. 크실렌 및 헥산 역시 48시간 반응 후에 E값이 100(153.91 및 129.95)을 초과하므로 라세미 화학물 1의 PPL-효소에 의한 가수분해의 동적분할에 효과적임을 알 수 있다. 특히 이 두용매 역시 모두 반응 3시간 후에 우수한 입체선택성을 가지고(95.3%, 89.0%), 반응 48시간 후에는 꾸준히 ee%값이 증가하여 98.0%, 96.2%의 값을 나타낸다. Table 2 shows the approximate indicators of the correlation between PPL-enzyme hydrolysis and log P in the solvent mixture of 10 organic solvents and buffers in a 1: 1 volume ratio. According to Table 2, the log P value of the solvent and the stereoselectivity of the hydrolysis of the PPL enzyme in the buffer-organic solvent are not directly proportional, but xylene, cyclohexane and hexane (numbers 8 to 10, log P are 3.10 to 3.50 Value) is very effective for hydrolysis of racemic compound 1 by PPL. In particular cyclohexane (number 9) showed the highest 99.5ee% and E (> 200) values among these three solvents after 48 hours reaction. Xylene and hexane are also effective for the dynamic splitting of hydrolysis by PPL-enzyme of racemic chemical 1 since the E value exceeds 100 (153.91 and 129.95) after 48 hours reaction. In particular, both of these solvents also had excellent stereoselectivity after 3 hours of reaction (95.3%, 89.0%), and after 48 hours of reaction, the ee% value increased steadily to show values of 98.0% and 96.2%.

또한, 에틸에테르 및 톨루엔은 반응 초기 3시간에는 우수한 결과를 나타내었으며, (번호 6 및 7), 물과 매우 잘 혼합되는 메탄올 및 아세톤은 역시 적당한 E값을 가졌다(번호 2 및 4). In addition, ethyl ether and toluene showed good results in the first 3 hours of the reaction (numbers 6 and 7), and methanol and acetone mixed very well with water also had appropriate E values (numbers 2 and 4).

Claims (11)

라세미체인 하기 화학식1 화합물을 유기용매의 극성도와 관계된 log P값이 3.00 내지 3.50인 유기용매 및 완충액이 1:1 부피비로 혼합된 용매 또는 크실렌(xylene) 중에 효소 PPL(porcine pancreatic lipase)로 가수분해시켜 동적분할하는 단계를 포함하는 광학이성질체인 화학식2 화합물의 제조방법:The compound of formula 1, which is a racemate, is synthesized with an enzyme PPL (porcine pancreatic lipase) in a solvent or xylene in which an organic solvent having a log P value of 3.00 to 3.50 related to the polarity of the organic solvent and a buffer are mixed in a 1: 1 volume ratio. Method for preparing a compound of formula (2) is an optical isomer comprising the step of resolving and dynamic splitting: [화학식1] [Formula 1]
Figure 112010033316810-pat00009
Figure 112010033316810-pat00009
[화학식2](2)
Figure 112010033316810-pat00010
Figure 112010033316810-pat00010
상기식에서,In this formula, Ac는 아세틸기를 의미하며, Ac means an acetyl group, X는 C1~C6의 알칸, C2~C3의 알켄, 벤젠 또는 나프탈렌이며, 여기서 알칸 및 알켄은 비치환되거나, 플로로, 클로로, 브롬, 요오드, 니트로, 벤젠, 나프탈렌으로 1이상 치환된 것이다. X is C1 to C6 alkanes, C2 to C3 alkenes, benzene or naphthalene, wherein alkanes and alkenes are unsubstituted or substituted one or more with fluoro, chloro, bromine, iodine, nitro, benzene, naphthalene.
제1항에 있어서, X가 벤질인 제조방법.The process of claim 1 wherein X is benzyl. 삭제delete 삭제delete 삭제delete 삭제delete 제1항에 있어서, 유기용매가 크실렌, 시클로헥산 또는 헥산인 제조방법.The process according to claim 1, wherein the organic solvent is xylene, cyclohexane or hexane. 제1항 또는 제7항에 있어서, 완충액이 포스페이트 완충액인 제조방법.8. The method of claim 1 or 7, wherein the buffer is phosphate buffer. 제8항에 있어서, 완충액의 pH가 6.5 내지 7.9인 제조방법.The method of claim 8, wherein the pH of the buffer is 6.5 to 7.9. 제9항에 있어서, 완충액의 pH가 7.2인 제조방법.The method of claim 9, wherein the pH of the buffer is 7.2. 제1항, 제2항 및 제7항 중 어느 한 항에 있어서, 반응온도가 25℃인 제조방법. The manufacturing method of any one of Claims 1, 2, and 7 whose reaction temperature is 25 degreeC.
KR1020080024937A 2008-03-18 2008-03-18 The Novel Preparation Method Of 2R,3S-3-substitutedmethyl-oxiran-2-yl methanol KR100981555B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080024937A KR100981555B1 (en) 2008-03-18 2008-03-18 The Novel Preparation Method Of 2R,3S-3-substitutedmethyl-oxiran-2-yl methanol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080024937A KR100981555B1 (en) 2008-03-18 2008-03-18 The Novel Preparation Method Of 2R,3S-3-substitutedmethyl-oxiran-2-yl methanol

Publications (2)

Publication Number Publication Date
KR20090099763A KR20090099763A (en) 2009-09-23
KR100981555B1 true KR100981555B1 (en) 2010-09-10

Family

ID=41358219

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080024937A KR100981555B1 (en) 2008-03-18 2008-03-18 The Novel Preparation Method Of 2R,3S-3-substitutedmethyl-oxiran-2-yl methanol

Country Status (1)

Country Link
KR (1) KR100981555B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278070A (en) * 1990-04-26 1994-01-11 Arco Chemical Technology, L.P. Process for producing epoxyalcohols of high optical purity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278070A (en) * 1990-04-26 1994-01-11 Arco Chemical Technology, L.P. Process for producing epoxyalcohols of high optical purity

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Tetrahedron 56, 9281-9288 (2000)
Tetrahedron: Asymmetry (2004), 15(24), 3945-3954
Tetrahedron: Asymmetry 16(23): 3841-3847 (2005.11.28)

Also Published As

Publication number Publication date
KR20090099763A (en) 2009-09-23

Similar Documents

Publication Publication Date Title
KR101132152B1 (en) Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition
Das et al. Stereoselective total synthesis of (+)-strictifolione and (6R)-6 [(E, 4R, 6R)-4, 6-dihydro-10-phenyl-1-decenyl)-5, 6-dihydro-2H-2-pyrone
Ayhan et al. Benzaldehyde lyase catalyzed enantioselective self and cross condensation reactions of acetaldehyde derivatives
JPH05331128A (en) @(3754/24)r)-@(3754/24)-)-4-cyano-3-hydroxylactic acid t-butyl ester and its production
Nakamura et al. Lipase-catalyzed kinetic resolution of 3-butyn-2-ol
Milner et al. Efficient kinetic bioresolution of 2-nitrocyclohexanol
KR100981555B1 (en) The Novel Preparation Method Of 2R,3S-3-substitutedmethyl-oxiran-2-yl methanol
KR100981532B1 (en) The novel preparation method of 2S,3S-3-substitutedmethyl-oxiran-2-yl methanol
Fischer et al. Efficient synthesis of either enantiomer of ethyl 5‐hydroxyhept‐6‐enoate
KR101180188B1 (en) A method for forming an alcohol enatiomer compound
Wang et al. Synthesis of trifluoromethylated analogues of β-l-fucofuranose and β-l-4, 6-dideoxyxylohexopyranose
Kitayama et al. Efficient synthesis of an optically active tetrahydrozerumbone exhibiting a fragrance and the application of zerumbone derivatives with a medium ring structure
Fryszkowska et al. One-pot enzymatic desymmetrization and Ugi MCR
JP2010229097A (en) New oxazolidine derivative, new oxazolidine derivative salt and method for producing optically active compound using the oxazolidine derivative salt as asymmetric organic molecular catalyst
JP5301432B2 (en) Esters of (2-hydroxy-3-oxo-cyclopent-1-enyl) acetic acid, (-)-R-homocitrate gamma-lactone, (+)-S-homocitrate gamma-lactone, and the corresponding (-)- Use of esters to produce R-homocitrate and (+)-S-homocitrate
Du et al. Alkyl 2-(2-benzothiazolylsulfinyl) acetates as useful synthetic reagents for alkyl 4-hydroxyalk-2-enoates by sulfinyl-Knoevenagel reaction
JP6214567B2 (en) Method for decomposing cyclopropyl diester
JP6979193B2 (en) Method for synthesizing α, β-unsaturated-γ-lactone derivative
Larsson et al. Enantiopure building blocks for the synthesis of 3-methyl-2-alkanols. Diastereoselective methylmetal addition to a chiral 2-methylaldehyde followed by lipase catalysed esterification
Bellur et al. Enantioselective synthesis of 2-alkylidenetetrahydrofurans based on a ‘cyclization/enzymatic resolution’strategy
US7524978B2 (en) 2-oxabicyclo[3.3.0]octane compounds, process for producing the same, optical resolver, method of separating diastereomer mixture, and method of optically resolving alcohol
JP4661272B2 (en) Process for producing chiral 4-methyl-4-[(arylcarbooxy) ethyl] -oxetan-2-one and chiral mevalonolactone
Mori et al. Synthesis of mono-and sesqui-terpenoids. XXI: Synthesis and absolute configuration of (E)-3-formyl-(2, 6, 6-trimethyl-2-cyclohexenyl)-3-pentenal, a sesquiterpenoid from a murine alga, Caulerpa ashmeadii
Omar et al. Scaling-up the production of 13S-hydroxy-9Z, 11E-octadecadienoic acid (13S-HODE) through chemoenzymatic technique
Lindström et al. Synthesis of diastereo-and enantiomerically pure anti-3-methyl-1, 4-pentanediol via lipase catalysed acylation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130514

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20140512

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee